Recently, Radiology, the world's top journal of radiology, released a research paper "Deep Learning for Head and Neck CT Angiography: Stenosis and Plaque Classification" by the team of Professor Lu Jie of Xuanwu Hospital of Capital Medical University. This is the first time in the world to apply deep learning technology to the study of head and neck CTA stenosis and plaque typing, and the first time to obtain the multi-center verification results of head and neck CTA AI clinical diagnosis high availability, leading the industry in the field of cerebrovascular AI from image reconstruction to auxiliary diagnosis a new stage.
The results of this scientific research cooperation between Shukun Technology and Professor Lu Jie of Xuanwu Hospital show that the head and neck CTA AI of Shukun Technology has significantly improved the accuracy of clinical diagnosis, reduced the diagnosis time by more than half, and reached the diagnostic level comparable to that of human senior doctors through multi-center verification. The "Digital Brain" product portfolio first launched by Shukun Technology has taken the lead in the industry to obtain both China's NMPA Class III certificate, EU MDR CE certification and US FDA certification. China's medical imaging research capabilities and new technology applications have been recognized by the world, especially in the field of stroke AI, China's practice, is continuing to lead the international medical AI scientific research innovation and clinical application development.
Cracking the complex cerebrovascular "maze"
Solve the problem of head and neck CTA AI stenosis and plaque typing
The National Health Commission pointed out in the newly released "Guidelines for the Prevention and Treatment of Stroke in China (2021 Edition)" that cerebrovascular disease has now jumped to the top cause of death in the country, of which stroke is the disease with the highest disability rate of a single disease. Ischemic stroke accounts for about 80% of brain tissue damage caused by blockage of blood vessels, which prevents blood from flowing into the brain.
The degree of vascular stenosis and plaque typing are the main bases for the clinical selection of ischemic stroke treatment regimens. However, due to the large range of head and neck, the twisted shape of the dendritic blood vessels and closely related to the skull, there have been no successful cases of applying deep learning technology to the degree of stenosis and plaque typing of head and neck CTA in the industry before.
The scientific research cooperation between Shukun Technology and Professor Lu Jie of Xuanwu Hospital not only solved the tortuous and complex cerebrovascular "maze" for the first time in the world, but also achieved excellent results in significantly improving diagnostic accuracy and reducing diagnosis time by more than half, and reached the same diagnostic level as human senior doctors through multi-center verification, which is the first successful practice to solve the problem of head and neck CTA AI stenosis and plaque classification.
Comparison of AI stricture diagnosis and doctor stenosis diagnosis
First launch of the "Digital Brain" product portfolio
Cerebrovascular AI has entered a new stage of auxiliary diagnosis from image reconstruction
Radiology, a top journal in radiology, published the pioneering research results of Shukun Technology and Professor Lu Jie of Xuanwu Hospital in applying deep learning technology to the degree of stenosis and plaque typing of head and neck CTA, which actually proved to the academic community and the industry that China's medical imaging AI scientific research ability in the field of diagnosis and treatment of cerebrovascular diseases is at the world's first-class level.
As the world's leading smart medical and health technology platform, Shukun Technology insists on providing smart products and innovative solutions for the medical and health industry with China's original and world-leading technologies. With the maturity of AI technology in head and neck image reconstruction, Shukun Technology took the lead in completing the successful application of head and neck CTA AI in the field of vascular stenosis diagnosis and plaque typing, and launched the "digital brain" auxiliary diagnosis product portfolio, promoting the field of cerebrovascular AI from image reconstruction to a new stage of assisted diagnosis, and setting a new world benchmark for the clinical application and practice of the industry in the field of cerebrovascular AI.
Case presentation by AI and doctors diagnosed at critical values
Polish China's scientific and technological innovation business card
The "digital human body" solves the problem of innovation in the world's practice
This scientific research cooperation project between Shukun Technology and Professor Lu Jie of Xuanwu Hospital was funded and supported by the National Natural Science Foundation of China. The phased scientific research results were included in the world's top journals and quickly transformed into mature products to empower clinical applications, which fully proves that China's medical imaging AI's scientific research strength and industrial practice are at the forefront of the industry in the world.
By building the world's leading medical and health brain "digital human body", Shukun Technology has independently developed a "digital doctor" product portfolio covering the whole process of disease screening, auxiliary diagnosis and treatment decision-making for major common diseases and chronic diseases such as cardiovascular and cerebrovascular diseases and tumors. Since the start of the research and development of cardiovascular AI in 2017, from 2018 to 2022, Shukun Technology has continuously launched digital heart AI, digital brain AI, digital chest AI, digital abdominal AI and other products at a rate of one per year, and its digital doctor products have been used daily with high viscosity in nearly 3,000 medical and health institutions across the country, including more than 90% of the top 100 hospitals and 80% of the target public tertiary hospitals, ranking first in the industry in market coverage. At present, Shukun Technology is the only medical AI enterprise in the world that has obtained NMPA Class III certificate + MDR CE certification in key fields of heart, brain and chest.
Adhering to the actual frontier of science and technology, the main battlefield of the economy, the major needs of the country, and the people's life and health are the four requirements put forward by the party and the state for scientific and technological innovation. Chinese science and technology enterprises represented by Shukun Technology not only actively promote the development of science and technology, but also take the initiative to give back to the society with the latest achievements of scientific and technological development. In the future, China's AI will play an increasingly important role in solving the practical innovation of world problems, and the world business card of China's scientific and technological innovation will become more and more dazzling.